They keep adding lots for him private channel from pharmacies and vaccinations. Those of Abbott; Sanofi; and GSKnow I know added one from Australian Seqirus. As well games are reinforced for him Public ambit.
–
After the ANMAT is approved lots from different multinational laboratoriesAh Orale the turn has come to an endorsement for Australian Seqirus. See list as of 05/04
Today was added a game of the anti-flu vaccine tetravalent Afluria Quadfor the purposes of commercialize on pharmacies and vaccinations. It adds to the two lots that were authorized from Influvac Tetra, from norteamericana Abbott; to others From from Istivac 4from francesa Sanofi; already one from Fluarix Tetrafrom británica GSK. So, to date, there is a total 6 lots supported for the private channelwhich are marketed yet average price of $4,000 (u$s 34.14). See article Sanofi and GSK join forces with flu batches
For him public sectorInstead, they joined two new lots from Fluxvir and a new batch from Virafluof the consortium Synergy Biotech. At the moment there is a list total of 21 gamesof which 13 match to trivalent vaccine Viraflu; five a Fluxvir; and three to pediatric version from Viraflu.
On 2021and according to own survey made by Pharmabizthe ANMATwhose owner is manuel limeresendorsed a total of 60 games. Of that number, 42 were destined for Public ambit and 18 they went for market in the private circuit. See article Flu vaccines 2021
u$s 1 = $117.14 (BCRA quote as of Tuesday 04/05/2022 11AM)
–
